Erratum: Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients | Zendy

AI Assistant Blog Pricing

Erratum: Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.